Dose response of umeclidinium administered once or twice daily in patients with COPD: a randomised cross-over study

BACKGROUND: Umeclidinium bromide (UMEC) is an inhaled long-acting muscarinic antagonist in development for chronic obstructive pulmonary disease (COPD). METHODS: This was a multicentre, randomised, double-blind, placebo-controlled, three-way cross-over, incomplete block study to evaluate UMEC 15.6,...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Church, Alison, Beerahee, Misba, Brooks, Jean, Mehta, Rashmi, Shah, Palvi
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BioMed Central 2014
Onderwerpen:
Research Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4029330/
https://ncbi.nlm.nih.gov/pubmed/24393134
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2466-14-2
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items